STOCK TITAN

TransMedics to Present at the Canaccord 40th Annual Growth Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

TransMedics Group, Inc. (Nasdaq: TMDX), a leader in organ transplant technology, will present at the Canaccord 40th Annual Growth Conference on August 13, 2020, at 10:00 a.m. EDT. This virtual event aims to highlight their innovations in portable organ preservation and assessment, which are critical for improving transplantation outcomes for patients with end-stage heart, lung, and liver failure. A live and archived webcast will be available on their website.

Positive
  • None.
Negative
  • None.

ANDOVER, Mass., July 28, 2020 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, announced today that members of management will be presenting at the virtual Canaccord 40th Annual Growth Conference. The presentation will take place on Thursday, August 13, 2020 at 10:00 a.m. EDT.

Event: Canaccord 40th Annual Growth Conference
Date: Thursday, August 13, 2020
Time: 10:00 a.m. EDT

A live and archived webcast of the event will be available on the “Investors” section of the TransMedics website at www.transmedics.com

About TransMedics Group, Inc.

TransMedics is the world’s leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung and liver failure.

Investor Contact:
Brian Johnston
631-807-1986
Investors@transmedics.com


FAQ

When is TransMedics presenting at the Canaccord 40th Annual Growth Conference?

TransMedics will present on August 13, 2020, at 10:00 a.m. EDT.

What is the main focus of TransMedics' technology?

TransMedics focuses on portable extracorporeal warm perfusion and organ assessment for transplantation.

Where can I watch the TransMedics conference presentation?

The presentation will be available as a live and archived webcast on the TransMedics website.

What is the ticker symbol for TransMedics Group?

The ticker symbol for TransMedics Group is TMDX.

TransMedics Group, Inc.

NASDAQ:TMDX

TMDX Rankings

TMDX Latest News

TMDX Stock Data

2.84B
33.56M
3.18%
107.49%
19.19%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
ANDOVER